Delfi Diagnostics Adds Reimbursement, Regulatory Leaders to Management Team
/PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, added...
Source: prnewswire.com